Erlotinib usage after prior treatment with gefitinib in advanced non-small cell lung cancer: A clinical perspective and review of published literature.
about
Clinical analysis of sixty-four patients with T1aN2M0 stage non-small cell lung cancer who had undergone resection.USP8: a novel therapeutic target for Cushing's disease.Comparison of Symptom Score and Bronchoscopy-Based Assessment With Conventional Computed Tomography-Based Assessment of Response to Chemotherapy in Lung Cancer.
P2860
Erlotinib usage after prior treatment with gefitinib in advanced non-small cell lung cancer: A clinical perspective and review of published literature.
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Erlotinib usage after prior tr ...... eview of published literature.
@ast
Erlotinib usage after prior tr ...... eview of published literature.
@en
Erlotinib usage after prior tr ...... eview of published literature.
@nl
type
label
Erlotinib usage after prior tr ...... eview of published literature.
@ast
Erlotinib usage after prior tr ...... eview of published literature.
@en
Erlotinib usage after prior tr ...... eview of published literature.
@nl
prefLabel
Erlotinib usage after prior tr ...... eview of published literature.
@ast
Erlotinib usage after prior tr ...... eview of published literature.
@en
Erlotinib usage after prior tr ...... eview of published literature.
@nl
P2093
P2860
P356
P1476
Erlotinib usage after prior tr ...... eview of published literature.
@en
P2093
Aditya Jindal
Digambar Behera
Navneet Singh
P2860
P304
P356
10.5306/WJCO.V5.I5.858
P577
2014-12-01T00:00:00Z